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Summary
Background: Cell adhesion and motility are accom-
plished through a functional linkage of the extracellular
matrix with the actin cytoskeleton via adhesion com-
plexes composed of integrin receptors and associated
proteins. To determine whether this linkage is attained
actively or passively, we isolated integrin complexes
from nonadherent hematopoietic cells and determined
their influence on the polymerization of actin.
Results: We observed that aVb3 complexes are capable
of dramatically accelerating the rate of actin assembly,
resulting in actin fibers tethered at their growing ends
by clustered integrins. The ability to enhance actin poly-
merization was dependent upon Arg-Gly-Asp-ligand-
induced b3 tyrosine phosphorylation, agonist-induced
cellular activation, sequestration of Diaphanous for-
mins, and clustering of the receptor.
Conclusions: These results suggest that adhesion
complexes actively promote actin assembly from their
cytosolic face in order to establish a mechanical linkage
with the extracellular matrix.
Introduction
Developmental processes and resolution of pathologic
events require adaptation of cellular attachments to me-
diate a range of events from firm adhesion to rapid mi-
gration within complex tissues. The observed cellular
phenotypes reflect actin cytoskeletal arrangement un-
der the guidance of integrin receptor adhesions and
the influence of inflammatory mediators and growth fac-
tors. These dynamics are particularly evident in hemato-
poietic cells that exhibit rapid adhesion-site and cyto-
skeletal turnover during immune surveillance. Integrin
receptors were aptly named for their unification of fibril-
lar extracellular matrices and polymerized actin cyto-
skeletons into a structural unit of significant tensile
strength [1]. Successful formation of these structural
units, varying in forms known as focal contacts, focal
adhesions, or podosomes, is particularly critical in he-
matopoietic cell resistance to deadhesion sheer forces
during vascular egress [2]. Numerous integrin features
are known to contribute to successful cytoskeletal-
matrix linkages, including regulated affinity for ligands
[3] and phosphorylation-dependent exposure of binding
*Correspondence: blystons@upstate.edumotifs that are contained within the cytoplasmic tails
and recruit adaptor and signaling proteins [4].
Recognition of the authority of Rho-family GTPases in
cytoskeletal organization has correctly guided studies
of both integrin signaling and actin nucleation. Current
models generally agree that, for example, lamellipodial
formation and cell motility result from Rac and Cdc42
activation, whereas firm cell adhesion and stress-fiber
formation result from Rho dominance [5]. Recent work
has shown that Rho-family GTPases are responsible
for activation of proteins upstream of actin nucleation
[6]. Despite exhibiting activation and localization of
Rho-family GTPases, integrin adhesion complexes are
usually depicted in models as passive recipients of pre-
formed actin fibers. These models reflect a historical
perspective of integrins’ anchorage function and predict
a cytosolic site of actin assembly. However, proteins
that directly nucleate actin, including formins and the
Arp2/3 complex, have been demonstrated to localize
to adhesion sites [7–9]. Formins are a family of actin-nu-
cleating proteins that, in some cases, are activated by
direct binding of Rho GTPases [6, 10]. The Diaphanous
formins produce linear actin filaments as seen in stress
fibers and filopodia [11, 12], whereas Arp2/3 is a multi-
protein complex that initiates new actin filaments at dis-
creet angles to existing filaments [13].
An understanding of the confluence of integrin signal-
ing and actin nucleation has evaded direct study despite
significant advances in both fields. We present direct
demonstration of actin polymerization occurring at puri-
fied integrin adhesion complexes and speculate that this
mechanism may play a role in the production of stress-
fiber-anchored adhesions.
Results
Actin Assembly by b3 Integrins Requires Integrin
Activation and b3 Tyrosine Phosphorylation
Hematopoietic cells expressing Y747, 759F b3 integrins
fail to firmly adhere to vitronectin (Vn) and fail to organize
their actin cytoskeleton into stress fibers, despite the
presence of cellular agonist (Figure 1A) [14]. Having pre-
viously demonstrated a deficient recruitment of actin-
nucleating proteins by phosphorylation-deficient b3
integrins [8], we developed an in vitro assay to visualize
and quantify actin polymerization from purified aVb3
integrin complexes. Bead-associated receptor com-
plexes (BARCs) were prepared from suspension K562
cells, a monocytic cell line, expressing wild-type or
Y747, 759F b3 following treatment with (stimulated) or
without PMA (Phorbol myristate acetate,10 ng/ml) and
RGD (Arg-Gly-Asp,1 mM) peptide. BARCs were pre-
sented to an actin-polymerization assay containing mo-
nomeric FITC-actin solution (2.4 mM) for 1 hr to permit
actin assembly. Bead-associated and supernatant frac-
tions were magnetically separated, and FITC fluores-
cence within each fraction was determined. In quiescent
cells expressing either wild-type or Y747, 759F aVb3, the
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243Figure 1. Actin Assembly from aVb3 Integrin
Complexes Mimics the Ability of aVb3-Ex-
pressing Cells to Adhere to Vn
(A) K562 cells expressing wild-type or Y747,
759F b3 were allowed to adhere to Vn for 1 hr
in the presence or absence of PMA (10 ng/
ml) and quantitated (n = 60 wells) or stained
with rhodamine phalloidin (representative).
(B) aVb3 BARCs were presented to an actin-
polymerization assay containing FITC-actin.
FITC fluorescence was determined for
BARC-associated and the supernatant frac-
tions. Data are presented as the percentage
of total fluorescent actin; shown are the
means 6 standard deviation (SD) of 23 ex-
periments.
(C) aVb3 BARCs were prepared from K562
cells, expressing wild-type or Y747, 759F b3,
incubated with or without PMA (10 ng/ml)
and RGD (1 mM) and presented to an actin-
polymerization assay containing pyrene-
actin, and pyrene fluorescence was moni-
tored over time and expressed as relative
fluorescence units (RFU). Shown is a repre-
sentative graph of 15 separate experiments.majority of actin was retained within the supernatant
fraction (Figure 1B). When K562 cells expressing wild-
type aVb3 were stimulated prior to receptor harvest, we
observed a 4-fold increase in FITC-actin within the
BARC-associated fraction and a corresponding de-
crease in FITC-actin within the supernatant fraction
(Figure 1B). However, no such increase occurred with
stimulated Y747, 759F b3 BARCs (Figure 1B). Minimal
FITC-actin was associated with BARCs prepared from
K562 cells lacking aVb3 expression or with untreated or
antibody-coated beads alone (data not shown).
To determine whether active avb3 complexes initiated
de novo actin polymerization, we employed pyrene-
labeled actin because this label fluoresces in linear pro-
portion to actin-filament assembly. When avb3 BARCs
were presented to an actin-polymerization assay con-
taining pyrene-actin (1:10 labeled to unlabeled) (2.4
mM), we measured a significant increase in the rate of ac-
tin assembly from stimulated wild-type aVb3 BARCs
when compared to unstimulated wild-type aVb3 (Fig-
ure 1C). Actin assembly reached half-maximal value
at 100 s with stimulated BARCs compared to 500 s for
unstimulated BARCs. The increase in rate of actin as-
sembly in the presence of active BARCs suggests the
presence of an actin nucleator. The rate of actin poly-
merization was further reduced when BARCs wereisolated from unstimulated or stimulated cells express-
ing Y747,759F b3 (Figure 1C). Equivalent actin polymer-
ization occurred in the presence of BARCs from untrans-
fected K562 cells, anti-b3-mAb-7G2-coated beads,
beads alone, or BARCs isolated from unstimulated
K562 cells expressing Y747,759F aVb3 (data not shown).
As detailed in the Supplemental Data available online,
actin assembly by avb3 was solely dependent upon
Tyr747 of b3 and unaffected by introduced b3 mutations
that mimic Glanzmann’s Thrombasthenia (Figure S1)
[15, 16]. Assembly of actin by avb3 BARCs from nonhe-
matopoietic cells was constitutive and did not require
phosphorylation of b3 tyrosines, in agreement with ob-
servations that b3 tyrosine phosphorylation is required
only for hematopoietic cell adhesion to vitronectin [4]
(Figure S1).
Selective Inhibition of aVb3-Mediated
Actin Assembly
Regulated aVb3-mediated adhesion of leukocytes re-
quires tightly controlled signaling events downstream
of integrin ligation. In previous studies, we have demon-
strated that inhibition of Src (PP1, 50 nM), Syk (picea-
tannol, 50 mg/ml), and PI3K (wortmannin, 10 mM) activity
disrupts aVb3-mediated adhesion to Vn, even in the
presence of PMA [17]. In contrast, inhibition of ROCK
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bly by aVb3 BARCs
(A) aVb3 BARCs were isolated from K562 cells
expressing wild-type b3 in the absence of
PMA (10 ng/ml) and RGD (1 mM) (no stimula-
tion) or in the presence of PMA (10 ng/ml) and
RGD (1 mM) with or without (PP1, 50 nM),
(wortmannin, 10 mM), (Y27632, 10 mM), or
(piceatannol, 50 mg/ml). Additionally, purified
aVb3 BARCS were phosphatase treated prior
to incubation with actin-polymerization as-
says. aVb3 BARCs were presented to an ac-
tin-polymerization assay containing pyrene-
labeled actin, and pyrene fluorescence was
monitored and expressed as relative fluores-
cence units (RFU). Experiment shown is a rep-
resentative graph of ten separate experi-
ments.
(B) Shown is a representative western blot
with anti-b3 mAb and anti-b3 Y747 PSSA
pAb (b3
Y747-P) on purified aVb3 receptor com-
plexes prepared from K562 cells expressing
wild-type aVb3 in the absence or presence
of PMA (10 ng/ml) and RGD (1 mM) with or
without PP1, 50 nM; wortmannin, 10 mM,
Wort; Y27632, 10 mM; or piceatannol, 50 mg/
ml, Pic. An additional sample prepared
from K562 cells expressing wild-type aVb3
in the presence of PMA (10 ng/ml) and
RGD (1 mM) was treated with phosphatase
(ptpase).
(C) aVb3 BARCs were isolated from K562 cells
expressing wild-type b3 in the absence of
PMA (10 ng/ml) and RGD (1 mM) (2) or in
the presence of PMA (10 ng/ml) and RGD
(1 mM) (+) with or without anti-Arp2/3 (anti-
p34 Arc/ARPC2). Additionally, purified aVb3
BARCS were isolated from K562 cells coex-
pressing wild-type aVb3 and the N terminus
of mDia1 (lacking the autoinhibitory domain).
aVb3 BARCs were presented to an actin-
polymerization assay containing pyrene-
labeled actin, and pyrene fluorescence was
monitored and expressed as relative fluores-
cence units (RFU). Experiment shown is a
representative graph of ten separate experi-
ments.(Y27632, 10 mM), a downstream Rho effector, does not
disrupt aVb3-mediated adhesion to Vn [8]. Following
these observations, we sought to determine whether
or not inhibition of these same signaling pathways might
disrupt the ability of purified wild-type aVb3 complexes
to orchestrate actin assembly. Inhibition of the activities
of Src with PP1, PI3K with wortmannin, or Syk with
piceatannol dramatically decreased the rate and extent
of aVb3-mediated actin assembly (Figure 2A), whereas
ROCK inhibition had no effect. Furthermore, inclusion
of cytochalasins eliminated all assembly, whereas la-
trunculin A pretreatment of purified BARCs had no influ-
ence (data not shown). Additionally, phosphatasetreatment of purified activated wild-type aVb3 receptor
complexes prior to presentation to the actin-polymeri-
zation assay disrupted aVb3-mediated actin assembly
(Figure 2A). Phosphotyrosine western blotting demon-
strated that inhibition of aVb3-mediated actin assembly
by PP1 or wortmannin was not due to a lack of b3 Tyr
747 phosphorylation, because these inhibitors did not
disrupt ligand-induced b3 Tyr phosphorylation (Fig-
ure 2B). However, either phosphatase treatment of puri-
fied activated wild-type aVb3 receptor complexes or
piceatannol treatment prior to BARC preparation dis-
rupted b3 Tyr 747 phosphorylation and subsequent
aVb3-mediated actin assembly (Figures 2A and 2B)
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245Figure 3. Receptor Density Determines the
Actin-Polymerization Potential of Purified
aVb3 Complexes
(A) Representative anti-b3 western blot of pu-
rified aVb3 receptor complexes prepared from
K562 cells expressing wild-type aVb3 presti-
mulated with PMA (10 ng/ml) and RGD
(1 mM) incubated with anti-mouse IgG-
coated paramagnetic beads coated with in-
creasing concentrations of anti-b3 7G2 (0.0–
1.0 mg/ml). Microscopic examination of
magnetic beads coated with increasing con-
centrations of anti-b3 mAb (0.0–1.0 mg/ml)
and incubated with K562 cells expressing
wild-type GFP-b3 following stimulation with
or without PMA (10 ng/ml) and RGD (1 mM).
aVb3 BARCs were examined by epifluores-
cence at 485/518 nm, and arrows indicate
clusters of GFP-b3. Bead diameter is 4.5 mm.
(B) Actin assembly from purified aVb3 com-
plexes requires a threshold of receptor
density. aVb3 BARCs were prepared with in-
creasing concentrations of anti-b3 mAb (0.0–
1.0 mg/ml) and from K562 cells expressing
wild-type aVb3 treated with PMA (10 ng/ml)
and RGD (1 mM) and presented for pyrene-
actin polymerization. Shown is representa-
tive of ten separate experiments. Legend in-
dicates coating concentration of anti-b3 mAb.
(C) Actin-filament concentrations from (B)
were determined from the slopes at 50% po-
lymerization. Shown are the means 6 SD for
ten separate experiments.
(D) Linear relationship between BARC con-
centration and rate of actin assembly. In-
creasing numbers of active aVb3 BARCs
were presented for pyrene-actin polymeriza-
tion. Shown is representative of ten separate
experiments. Legend indicates bead concen-
tration within each individual actin-polymeri-
zation assay.
(E) Actin-filament concentrations from (D)
were determined from the slopes at 50% po-
lymerization. Shown is the mean6 SD for ten
separate experiments.compared to negative (no PMA or RGD) and positive
(PMA, 10 ng/ml, and RGD, 1 mM) controls. These data
demonstrate that inhibition of specific signaling cas-
cades inhibits the ability of wild-type aVb3 complexes
to assemble actin and reorganize the actin cytoskeleton,
which is required for, and correlates with, their inhibition
of aVb3-mediated firm adhesion. We also sought to
determine the nucleation factors that might be responsi-
ble for aVb3-mediated actin assembly. Purification of
wild-type avb3 BARCs from K562 also expressing the
amino-terminal 600 aa of mDia1, known to inhibit in vitro
formin-mediated actin nucleation, caused a significant
decrease in the rate of actin assembly, whereas neutral-
ization of Arp2/3 with mAb had no effects on actin
assembly (Figure 2C). These data suggest that aVb3-
mediated actin assembly is formin mediated and not
Arp2/3 mediated.
Receptor Density Governs Actin-Polymerization
Capability of aVb3 Complexes
Because integrins perform adhesive function as clus-
ters, we manipulated the coating density of anti-b3
mAb 7G2 on the paramagnetic beads to alter the sizeof purified aVb3 receptor complexes. Western blotting
showed that with increased 7G2 coating concentra-
tions, there was a linear increase in the amount of mag-
netically recovered b3 (Figure 3A). Upon fluorescent
microscopic examination of beads incubated with stim-
ulated K562 cells expressing aVGFP-b3WT, we observed
the formation of visible GFP-b3 clusters, commencing at
0.35 mg/ml 7G2 and maintained at coating densities up
to 0.85 mg/ml (Figure 3A, shown by arrow). Although
clusters do form on beads incubated with unstimulated
K562 cells expressing wild-type aVb3, these clusters
were not visible until 7G2 coating densities exceeded
0.5 mg/ml, a concentration well below the 1.0 mg/ml
7G2 employed in our initial evaluation of actin assembly
from aVb3 complexes. Utilizing pyrene-actin-polymeri-
zation assays, we determined a receptor-clustering
threshold density that is required for aVb3-mediated ac-
tin assembly and corresponds to the coating density at
which we began to observe GFP-b3 cluster formation. At
concentrations of 0.45 mg/ml 7G2 and above, we ob-
served dramatic increases in the rates of actin assembly
(Figure 3B). Once the receptor-cluster size threshold
was achieved at a coating concentration of 0.35 mg/ml
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246Figure 4. Tyrosine-Phosphorylation-Deficient
aVb3 Integrins Are Incapable of Providing a
Platform to Promote Actin Assembly
aVb3 BARCs prepared from unstimulated
cells were incubated for 15 min at RT with
sonicates prepared from K562 cells express-
ing wild-type or Y747, 759F aVb3 integrins fol-
lowing incubation with (+) or without (2) PMA
(10 ng/ml) and RGD (1 mM). Reconstituted
aVb3 BARCs were presented to an actin-poly-
merization assay containing FITC-actin, and
fluorescence was determined for BARC-
associated fraction. Data are presented as
the percentage of total fluorescent actin.
Shown is the mean 6 SD of seven experi-
ments. Representative Pyk2Y402-P western
blots of aVb3 BARCs following reconstitution
with sonicates from K562 cells expressing
wild-type or Y747, 759F aVb3 treated with or
without PMA (10 ng/ml) and RGD (1 mM)
and corresponding representative western
blot of total Pyk2 in transferred sonicates
are shown.7G2, we calculated a significant increase in actin-
filament formation (Figure 3C) [18]. Significantly, post-
threshold concentrations of 7G2 (0.55 mg/ml and above)
produced no further increases in the rate of actin assem-
bly or filament formation (Figure 3C), and rates were
unaffected by higher actin concentrations, disregarding
monomer consumption in the assay (data not shown).
In contrast to the valency threshold, we observed a
linear relationship between the rates of actin assembly
as well as actin-filament formation and the number of
aVb3 BARCs within the actin-polymerization assay.
Paramagnetic beads were coated at 1.0 mg/ml 7G2,
and stimulated aVb3 BARCs were isolated. The number
of aVb3 BARC-coated beads was then varied from 1 3
104 to 1 3 106 beads per actin-polymerization assay,
and we observed a linear increase in the rate of actin as-
sembly and actin-filament formation with increasing
aVb3 BARC concentration (Figures 3D and 3E). Although
we observed a linear response with increasing BARC
concentration, these BARC molarities are lower than
concentrations of purified actin nucleators, such as for-
mins or Arp2/3, typically used for in vitro actin-polymer-
ization assays. Taken together, these data suggest that
receptor density is critical because it relates to the abil-
ity of integrin complexes to promote integrin-mediated
actin cytoskeletal reorganization required for integrin-
mediated adhesion.
A Mechanical Defect Prevents Actin Assembly
from Tyr747, 759Phe b3
The failure of cells expressing Y747, 759F mutant b3 to
firmly adhere to Vn is due in part to a disruption in
Rho-GTPase-dependent actin cytoskeletal reorganiza-
tion [14]. This defect in actin cytoskeletal reorganiza-
tion could result from a lack of signaling after receptor
ligation and/or cell activation or from an inability to
assemble a suitable cytoplasmic platform capable ofpromoting actin assembly. To distinguish between these
scenarios, we modified the actin assembly assay such
that BARCs were isolated from unstimulated cells ex-
pressing either wild-type or Y747, 759F b3. Parallel cell
aliquots were incubated with or without PMA (10 ng/ml)
and RGD (1 mM) and sonicated in suspension. Following
receptor harvest, the isolated, unstimulated BARCs
were incubated for 15 min with membrane-free cytosol
from sonicated parallel cell aliquots. The BARCs were
magnetically repurified and presented for actin assem-
bly. We observed that receptor complexes purified
from cells expressing wild-type b3 were able to orches-
trate actin assembly when treated with stimulated cyto-
sol from cells expressing either wild-type or Y747, 759F
b3 (Figure 4). However, purified aVb3 complexes from
cells expressing Y747, 759F b3 were unable to promote
actin assembly even when treated with cytosol from
stimulated cells expressing wild-type b3. We have previ-
ously shown that agonist activation of K562 cells ex-
pressing Y747, 759F b3 is capable of activating Pyk2
and PI3K within the cytosol [14, 17]. However, mutant re-
ceptors are incapable of supporting either Pyk2 or PI3K
association [14]. Western blotting of reconstituted
BARCs showed that exogenous, donor Pyk2Y402-P asso-
ciates with wild-type aVb3 receptors but not Y747, 759F
b3, present in unstimulated BARCs (Figure 4).
Activation- and b3 Phosphorylation-Dependent
Association of a Signaling Complex Capable
of Actin Polymerization
We evaluated aVb3 BARCs for the inclusion of proteins
previously shown to be present in adhesive structures.
Initial assessment of tyrosine phosphorylation and gross
protein content of isolated BARCs illustrated that there
are differences in protein composition as well as tyro-
sine-phosphorylation patterns between wild-type aVb3
integrin complexes isolated from PMA (10 ng/ml)- and
aVb3-Mediated Actin Assembly
247Figure 5. Protein Composition of Stimulated
versus Unstimulated aVb3 BARCs
(A) Left panel: Coomassie-stained gel of pro-
teins in aVb3 BARCs. Middle panel: western
blot of tyrosine-phosphorylated proteins in
aVb3 BARCs.
(B) Representative Arp2, Pyk2, talin, and ac-
tin western blots of proteins in aVb3 BARCs.
(C) Fluorescent or immunofluorescent locali-
zation of GFP-b3, GFP-Vav1, GFP-Paxillin,
GFP-mDia1 N terminus, or Pyk2Y402-P on
avb3 BARCs; arrow indicates cluster.
(D) Summary table of proteins associated
with aVb3 BARCs. All proteins except for the
N terminus of mDia1 and the C terminus of
hDia2 were determined by western blots of
isolated aVb3 BARCS. mDia1 N-terminus
and hDia2 C-terminus localizations were de-
termined by isolation of aVb3 BARCs from
K562 cells coexpressing wild-type or Y747,
759F b3 and GFP-mDia1 N terminus or GFP-
hDia2 C terminus prestimulated with or with-
out PMA (10 ng/ml) and RGD (1 mM) and GFP
fluorescence localization.
(E)Fluorescentor immunofluorescentcolocal-
izations of GFP-b3 and Paxillin or Pyk2
Y402-P
on stimulated avb3 BARCs.RGD (1 mM)-treated cells as compared to those isolated
from quiescent cells (Figure 5A). Although the overall
protein content appears to remain the same between
unstimulated and stimulated BARCs, we observed pro-
teins between 40 and 55 kDa, which appeared to in-
crease in concentration with stimulation. Additionally,
we observed a distinct loss of a w35 kDa protein that
corresponded to a loss of a phosphotyrosine protein
of comparable molecular weight. The majority of pro-
teins analyzed displayed no activation- or phosphoryla-
tion-dependent changes in their association with iso-
lated aVb3 complexes (Figure 5E). However, PI3K,
wild-type Vav1, Tyr Pyk2Y402-P, and activated Src were
associated only with wild-type aVb3 BARCs in an activa-
tion-dependent manner. Interestingly, we observed little
Arp2 association with activated aVb3 receptor com-
plexes (Figures 5B and 5E). Additionally, vinculin associ-
ation with aVb3 receptors diminished upon activation
with PMA (10 ng/ml) and RGD (1 mM) (Figure 5E).
We have previously shown that Pyk2 associates with
b3 in a Pyk2- and b3-phosphorylation-dependent man-
ner [17]. Here, we observed that Pyk2Y402-P clustered
in the same manner as wild-type aVb3, but, in contrast
to aVb3, was only found to be clustered on beads incu-
bated with PMA (10 ng/ml)- and RGD (1 mM)-stimulated
cells expressing wild-type b3 (Figure 5C). Recently, our
lab has shown that Tyr phosphorylation of both b3 andVav1 is required for their association, because there
is minimal association of Vav1 Y160F with wild-type
phosphorylated b3, as well as minimal wild-type Vav1
association with Y747, 759F b3 [19]. Here, we show
that GFP-Vav1, as with Pyk2Y402-P, forms clusters on
beads incubated with wild-type-b3-expressing cells in
an activation-dependent manner (Figure 5C). Addition-
ally, we observed no Vav1 clusters on beads incubated
with cells expressing Y747, 759F b3 or coexpressing
wild-type aVb3 and Vav1 Y160F (data not shown). Taken
together, these data suggest that Pyk2 and Vav1 are
localized to clusters in the same manner as b3, in an
activation- and b3-phosphorylation-dependent manner.
In contrast, we observed clusters of the prominent focal
adhesion protein paxillin forming independently of the
activation state of b3 (Figure 5C). Talin association with
aVb3 BARCs was slightly reduced by b3 phosphorylation
or activation (Figure 5B). We also observed colocaliza-
tion of clustered GFP-b3 with paxillin and Pyk2 Tyr
402P
(Figure 5D).
Recent work has shown that expression of an active
form of Dia promotes the constitutive formation of filo-
podia and is associated with Rac [12]. When we coex-
pressed a GFP-tagged mDia1 N terminus (gift of
Dr. Henry Higgs) in K562 with wild-type aVb3 and isolated
aVb3 receptor complexes, we observed GFP-mDia1
N-terminus clusters on beads that had been incubated
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aVb3 Receptor Complexes
(A) Two representative stimulated aVb3
BARCs from K562 cells expressing wild-
type GFP-b3, presented to an actin-polymer-
ization assay containing TRITC-actin and ob-
served by epifluorescence at 30 min.
(B) Stimulated aVb3 BARCs were presented to
an actin-polymerization assay containing
FITC-actin and observed by epifluorescence
at 5 min minute intervals from 0 to 30 min.
Shown are three separate aVb3 BARC-coated
beads.
(C) Time-course epifluorescence of an an-
chored-stimulated aVb3 BARC in the pres-
ence of FITC-actin. Bead diameter is 4.5 mm.
(D) Two representative stimulated aVb3
BARCs were presented to an actin-polymeri-
zation assay containing TRITC-actin for
15 min followed by the addition of FITC-actin
for 5 min. BARCs were then magnetically pu-
rified and subjected to epifluorescent micro-
scopic examination. Bead diameter is 4.5 mm.with cells treated with PMA (10 ng/ml) and RGD (1 mM)
(Figure 5C). As shown in Figure 2C, this association
drastically inhibited actin assembly by avb3 BARCs. In
contrast, a GFP-tagged C terminus of human Dia2, lack-
ing the autoregulatory (DID) domain and the RhoGTPase
binding domain, failed to localize with b3 clusters in
BARCs (Figure 5E).
Actin Assembly Occurs Proximal to the Purified
Integrin Complex
When we isolated aVb3 BARCs from cells expressing
GFP-b3 and utilized TRITC-labeled actin, we observed
red filaments emanating from distinct GFP-b3 clusters,
indicating that actin assembly occurs from the clustered
aVb3 complex (Figure 6A). Time-course observations of
wild-type aVb3 BARCs revealed actin filaments that in-
creased in length corresponding to an increase in the in-
cubation time (Figure 6B). The spherical beads are able
to move and rock; thus, the orientation and focus of the
actin filament is altered over time. When beads were
anchored on Ab-coated dishes, observation of actin
growth also shows increasing length of actin filamentover time (Figure 6C). Additionally, when we employed
a pulse-chase approach whereby we initiated the actin
polymerization with TRITC-labeled actin followed by
FITC-labeled actin, we observed that the addition of
new actin monomers was proximal to the bead surface
and not distally at the tip of the actin fiber (Figure 6D), in-
dicating that the actin-nucleation machinery is associ-
ated with the purified integrin complex.
Discussion
Within the progression of cell adhesion and motility,
both in vitro and in vivo, cells of diverse origins exhibit
a state of firm adhesion typified by spread morphologies
and the presence of large actin bundles, termed stress
fibers, originating from points of substrate contact. In
white blood cells, this firm adhesion is required for vas-
cular exit as well as for final arrest at inflammatory loci. In
studying hematopoietic cell adhesion, we have identi-
fied phosphorylation of Tyr747 within the b3 cytoplasmic
tail as a post-ligand-binding activation event for integrin
avb3. b3 integrins, although ubiquitously expressed,
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formation of the osteoclast sealing ring, monocyte
transmigration through endothelial monolayers, and
platelet-thrombus formation [20–23]. Ligand-induced
phosphorylation of the b3 cytoplasmic tail is required,
both in vitro and in vivo, for cell-adhesion and adhe-
sion-dependent events mediated by b3 integrins in he-
matopoietic cells [4, 8, 14, 15, 17, 19, 23]. A notable de-
fect in leukocytes bearing phosphorylation-deficient b3
integrins is their inability to organize the actin cytoskel-
eton into the typically prominent stress fibers, presum-
ably explaining their failure to firmly adhere [8, 14].
We have explored signaling specific to tyrosine-phos-
phorylated b3 integrins in order to explain its require-
ment in stress-fiber-formation-dependent cell adhesion.
We have previously reported that activation of Rho by its
GEF, Vav1, is defective in cells expressing nonphos-
phorylatable b3 integrins [14, 18]. As localization of ac-
tive Rho to b3 adhesion sites appeared to correlate
with the formation of stress fibers, we became inter-
ested in whether or not factors that initiate actin poly-
merization could also be recruited to the adhesion site.
Mimicking treatment conditions wherein expression
of wild-type aVb3 in a hematopoietic cell line results in
firm adhesion and stress-fiber formation, we purified
activated, tyrosine-phosphorylated aVb3 receptor com-
plexes and report here their ability to influence the poly-
merization of actin in an activation-dependent manner.
As is seen for avb3-mediated adhesion, actin assembly
was also dependent upon the recruitment and/or activa-
tion of Src, PI3K, Pyk2, Vav, Syk, and Rho. In contrast,
inhibition of ROCK, a downstream Rho effector that
blocks avb3-mediated adhesion, did not reduce actin
polymerization by avb3 complexes. This may relate to
observations that ROCK is required for early Arp2/3
localization to avb3 adhesions whereas the replacement
of Arp2/3 by Diaphanous formins within this complex
seems important for actin assembly [8]. Supporting this
is the coincident loss of vinculin, which has been impli-
cated in mediating Arp2/3 traffic to focal adhesions [9].
Upon cell contact with immobilized vitronectin, aVb3
rapidly localizes to small punctate foci containing clus-
tered b3 that is phosphorylated at Tyr747. Although we
are unable to distinguish a core/ring arrangement to
these structures, their rapid assembly, size, and colocal-
ization with vinculin and paxillin suggest relatedness to
podosomes, the typical leukocyte adhesion structure.
To determine whether or not clustering was important
for b3 integrin effects on actin polymerization, we exam-
ined beads used to purify GFP-conjugated b3 from acti-
vated K562 cells and found visible b3 clusters. Because
the paramagnetic beads used to harvest receptors were
shown to contact only a minimal region of the cells (Fig-
ure S2), we presume that receptor clustering occurs via
diffusion within the membrane to the point of contact.
PMA treatment of hematopoietic cells has been shown
to enhance lateral integrin membrane diffusion through
the release of cortical cytoskeletal restraints [24]. Given
that other work has shown that the number of integrin-
ligand contacts is proportional to the strength of adhe-
sion [25], we were not particularly surprised to find
that increasing the number of BARCs of the same recep-
tor density resulted in a linear increase in the quantity of
actin filaments generated. However, upon varyingreceptor-cluster size through antibody-coating manipu-
lation, we were surprised to observe a sharp threshold in
actin-filament generation. Equally surprising was a flat-
tening of this dose response for actin polymerization,
despite visual and biochemical evidence that integrin
cluster size continued to increase. The significance of
this limitation suggests contributing mechanisms, per-
haps organized actin-fiber bundling events, which are
not yet apparent. However, these studies provide a pos-
sible explanation for integrin clustering that may operate
in parallel to, or in combination with, the amplification of
signaling to produce an actin-linked adhesion site. Fur-
thermore, the linear response in actin assembly in as-
says mimicking varying number of equivalent contact
sites reinforces observations from experiments that
used varied substrate-coating densities to conclude
that adhesion strength is proportional to the number of
adhesion sites [26, 27].
To understand the deficiency in actin polymerization
from purified nonphosphorylatable b3 integrins, we uti-
lized a reconstitution assay where transferable cytosolic
signaling molecules were provided from sources dis-
tinct from those providing inactive purified receptors.
Concluding from these studies that cytoplasmic binding
motifs within the integrin were critical to actin-polymer-
ization activity, we examined reconstituted receptor
complexes for transferred proteins and found that active
Pyk2, previously shown to bind directly to phosphory-
lated b3, was transferred to aVb3 receptors that had
been harvested in an inactive state. We speculate that
this translocation is one component of an active com-
plex required for actin-polymerizing activity by integrin
receptor complexes and may serve as a scaffold for fur-
ther assembly. Significant among the protein-complex
dynamics observed was the decrease in Arp2/3 com-
plex between inactive and active BARCs, particularly
because we have previously shown a b3-tyrosine-phos-
phorylation-dependent early recruitment of Arp2/3 to
avb3 clusters. Coincident with the loss of Arp2/3, how-
ever, was the recruitment of a member of the formin fam-
ily of actin-nucleating proteins. Although incomplete re-
agents limit our interpretation of these studies, there is
a high degree of homology between the Diaphanous
members of the formin family [10]. Thus, it is interesting
that we observed recruitment of an amino-terminal, but
not a carboxy-terminal GFP-fusion of a Diaphanous
family member to active aVb3 BARCs. Moreover, the
presence of the Diaphanous inhibitory domain from
the amino terminus of mDia1 dramatically inhibited actin
assembly by avb3 complexes. In addition to this inhibi-
tion, the kinetics of in vitro actin assembly by BARCs
and the growth rate and linearity of visualized fibers em-
anating from BARCs are consistent with a formin-medi-
ated assembly mechanism [18].
The replacement of Arp2/3 with a formin protein frag-
ment in avb3 complexes when conditions are altered to
mimic actin-stress-fiber-dependent adhesion is espe-
cially interesting given findings that the linear actin pro-
duced by formin nucleation is unique from branched
Arp2/3-derived actin. We speculate that under these
conditions, formin-mediated actin assembly is most
suitable for the targeted cell phenotype, and the loss of
Arp2/3 may indicate the occurrence of such a transition.
It is likely that alternate stimuli recruit unique protein
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tures required to achieve a desired cell phenotype.
We were able to microscopically examine actin struc-
tures that associated with BARCs during the actin-poly-
merization assay. Using TRITC-labeled actin and
BARCs prepared with GFP-b3, we observed linear actin
filaments that originated at b3 clusters on the bead sur-
face and projected distances greater than 10 mm in
length from the bead surface. Observation of the time-
dependent extension of a single actin filament from the
bead surface revealed growth rates with monomer in-
corporation rates of w6.35 subunits/s, similar to rates
reported for purified formin-mediated assembly [28].
Of interest was the origin of actin growth; however, the
fragility of these structures prevented classical postas-
sembly decoration to determine barbed ends. To over-
come this limitation, we utilized a pulse-chase actin
assembly beginning with TRITC-actin and infusing
FITC-actin immediately prior to fluorescent visualiza-
tion. This technique clearly demonstrates incorporation
of new actin monomers proximal to the bead surface.
Together with formin localization to this complex and
formin-dependent assembly, we believe these data indi-
cate the initiation of formin-driven barbed-end growth of
actin from adhesion clusters.
Using an experimental approach bridging cell biology
and biochemistry, we demonstrate that integrin com-
plexes can influence actin polymerization and perhaps
function as nucleation centers through the recruitment
of proteins capable of actin-polymer assembly. These
results indicate that for some observed cellular pheno-
types, integrin adhesive sites are not simply passive re-
cipients of assembled actin fibers. Anticipated future
studies will characterize modifications at the adhesive-
site complex with regard to its actin-polymerization
capabilities through recruitment of specific actin-nucle-
ating proteins.
Experimental Procedures
Cells and Materials
K562 and CS-1 cells were stably transfected with cDNA encoding
wild-type b3 (KaVb3), Tyr747Phe b3 (KaVb3Y747F), Tyr759Phe
(KaVb3 Y759F), Ser752Pro b3 (KaVb3 S752P), Ser752Ala b3 (KaVb3
S752A), or Tyr747, 759Phe (KaVb3 Y747, 759F) together with aV and
maintained as previously described [15]. Also, K562 cells were sta-
bly transfected with b3 C-terminally tagged with green fluorescent
protein (GFP-b3). Additionally, KaVb3 cells were stably cotransfected
with GFP-paxillin, GFP-Vav1 wild-type, GFP-Vav1 Tyr 160 Phe (GFP-
Vav1Y160F), GFP-mDia1 N terminus, or GFP-hDia2 C terminus as
previously described [19]. The anti-b3 monoclonal antibodies 7G2
and LIBS-1 were gifts of Eric J. Brown and Mark H. Ginsberg, re-
spectively. Goat anti-mouse paramagnetic beads employed in
aVb3 receptor purification were purchased from Dynal (Lake Suc-
cess, New York). Nonlabeled, FITC- and, Pyrene-labeled actins
were purchased from Cytoskeleton (Denver, Colorado). All reagents
unless otherwise noted were purchased from Sigma (St. Louis, Mis-
souri). Quantitative adhesion assays were performed in microtiter
plates exactly as previously described [4].
Actin-Polymerization Assays
Goat anti-mouse paramagnetic 4.5 mm beads (Dynal) were coated
with antibody as per manufacturer’s protocol with anti-b3 mAb
7G2 (1 mg/ml) or as indicated. 53 106 K562 or CS-1 cells expressing
wild-type or mutant b3 integrins were incubated with or without PMA
(10 ng/ml) and RGD (1 mM) for 15 min at 37ºC in Iscove’s Modified
Dulbecco’s Media (IMDM) (Gibco, Carlsbad, California) containing
50 mM Na3VO4. Following stimulation, the cells were washed twicein IMDM and incubated with anti-b3-coated beads in IMDM at 4ºC
for 30 min at a ratio of six beads per cell. Cells in 1.5 ml microtubes
were restrained magnetically with Dynal MPC-S apparatus as de-
scribed by the manufacturer and washed twice in ice-cold IMDM.
Cells were sonicated with three consecutive 3 s pulses with an
amplitude of 30 Hz at 5 watts (Cole-Palmer) while magnetically
restrained. Inhibitors were added to cells prior to sonication: Src
(PP1, 50 nM), Syk (piceatannol, 50 mg/ml), PI3K (wortmannin,
10 mM), or ROCK (Y27632, 10 mM). The released cytosol was dis-
carded, and the isolated bead-associated receptor complexes
(BARCs) were washed twice in cold IMDM containing 1 mM
Na3VO4 and resuspended in G-buffer (2.0 mM Tris-HCl [pH 8.0],
0.1 mM CaCl2, 0.2 mM ATP, 0.1 mM DTT, and 1 mM Na3VO4).
Methods used for identification of proteins retained in BARCs can
be found in the Supplemental Data. A solution of 2.4 mM unlabeled
monomeric actin was prepared according to the manufacturer’s
protocol (Cytoskeleton). Actin solutions were centrifuged at
100,000 3 g for 1 hr prior to assay to remove multimeric actin com-
plexes. Actin was converted to Mg2+ actin by adding 0.1 volumes of
10 mM EGTA and 1 mM MgCl2 with incubation on ice for 5 min. Actin
was added to BARCs resuspended in G-buffer to a concentration of
2.4 mM with a ratio of 1:10 (labeled to unlabeled). Polymerization was
induced by the addition of 103 KMEI (500 mM KCl, 10 mM MgCl2, 10
mM EGTA, and 100 mM imidazole, pH 7.0) to a concentration of 13,
with the remaining volume made up by G-buffer. For FITC fluores-
cent quantification, BARCs were magnetically restrained and sepa-
rated from the supernatant after 30 min at 24ºC. BARCs were resus-
pended in an equal volume of actin stabilization buffer (0.5 mM
Tris-HCl [pH 8.0], 1 mM CaCl2, 0.05 mM DTT, 5 mM KCl, 2 mM
MgCl2, and 0.5 mM ATP). Fluorescent measurements were taken
on the resuspended BARC and supernatant fractions at 485 nm exci-
tation and 518 nm emission wavelengths in a Molecular Devices
Spectramax Gemini plate reader. For add-back assays, unstimulated
cells were incubated with anti-b3-coated magnetic beads and
BARCs were isolated as described above. These complexes were
then incubated with sonicates from 5 3 106 K562 cells expressing
wild-type or mutant integrins. Membrane-free sonicates were pre-
pared as follows: 53 106 K562 cells expressing wild-type or mutant
integrins were incubated with or without PMA (10 ng/ml) and RGD (1
mM) for 15 min at room temperature (RT) in IMDM. Sonication of
cells was then performed as described above. Sonicates were
then centrifuged at 14,000 3 g for 15 min at 4ºC. Following centrifu-
gation, sonicate was added to unstimulated BARCs for 15 min at
RT. BARCs were then magnetically repurified and presented to an
actin-polymerization assay as above. BARCs were magnetically re-
strained and separated from the supernatant after 30 min at 24ºC.
BARCs were resuspended in an equal volume of actin-stabilization
buffer, and fluorescent measurements were taken on the resus-
pended BARC and supernatant fractions as above. Kinetic actin-as-
sembly experiments were performed as above except that pyrene-
labeled actin was used at 2.4 mM and fluorescence was measured
at 365 nm excitation and 405 nm emission wavelengths every 6 s
for 7 min in a Molecular Devices Spectramax Gemini plate reader.
For Arp2/3 inhibition, the blocking Ab anti-p34 Arc/ARPC2 (BD Bio-
sciences) was added to BARCs in actin-polymerization cocktail and
incubated for 5 min prior to the addition of polymerization inducer.
Actin quantities are expressed as percentage of BARC-associated
fluorescence compared to total actin fluorescence for FITC experi-
ments, or as relative fluorescence units for pyrene experiments.
Actin-Polymerization Microscopy
Actin assembly from isolated aVb3-integrin complexes was visual-
ized by epifluorescence with a Hamamatsu C4742-98 camera on
a Nikon Eclipse TE 2000-U microscope and processed with Simple
PCI software. BARCs isolated from 5 3 106 K562 cells expressing
wild-type b3 treated with PMA (10 ng/ml) and RGD (1 mM) were incu-
bated with 2.4 mM Mg-actin (1:10 FITC-labeled to unlabeled), and
a 500 ml volume was loaded onto a 35 mm glass-bottom microwell
dish previously coated with rabbit anti-goat Ab (1 mg/ml) and allowed
to incubate for 15 min on ice. Five hundred microliters of 23 TIR
Buffer (20 mM Imidazole, pH 7.0, 2 mM MgCl2, 100 mM KCl, 50
mM DTT, 0.4 mM ATP, 30 mM glucose, 1% methylcellulose, 40 mg/
ml catalase, 200 mg/ml glucose oxidase) was loaded into the dish
and mixed followed by epifluorescence microscopy.
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Actin-filament concentrations were determined from the slopes at
50% polymerization according to the following equation: F = S*/
(M0.5 3 k+) where F is filament concentration in mM, S* is slope
(mM/s) and M0.5 is monomer concentration at 50% polymerization.
S* is calculated by S* = (S 3 Mt)/(fmax 2 fmin), where S is raw slope,
Mt is mM concentration of available actin monomer, and fmax and
fmin are fluoresecence of fully polymerized and unpolymerized actin,
respectively. Curve fits for kinetic actin-polymerization assays were
a second-order polynomial curve fit. Data are reported as means 6
standard error of the mean (SEM) of experiments repeated at least
three times. Significance above 95% was determined by Student’s
t test.
Supplemental Data
Supplemental Data, including Supplemental Results and Experi-
mental Procedures and two figures, are available with this article
online at: http://www.current-biology.com/cgi/content/full/16/3/
242/DC1/.
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